Genasys Pre-Announces Q3 Revenue Miss, but Sees Record Q4 as Supply Chain and Payment Delays Resolve
GNSS sits 24% above its 52-week low of $1.4.
Summary
Genasys pre-announced Q3 FY2026 revenue of $7.0–$7.5 million and an adjusted EBITDA loss of up to $3.3 million, citing temporary supply chain and payment delays. Both issues are resolved, and management expects a record Q4, keeping full-year guidance intact.
Key Events · Earnings and Guidance · GNSS
-
Q3 Revenue Miss
Preliminary Q3 FY2026 revenue of $7.0–$7.5 million, down sharply from $15.5 million in Q2, driven by temporary supply chain and payment delays.
-
Adjusted EBITDA Loss
Adjusted EBITDA loss of ($3.0)–($3.3) million, reflecting the revenue shortfall and ongoing operating costs.
-
Operational Headwinds Resolved
CROWS II supply chain constraints resolved; Puerto Rico EWS payments received and work remobilized—both expected to drive record Q4 revenue.
-
Backlog and Full-Year Outlook
Backlog of approximately $69 million supports management's expectation of a record Q4 and full-year guidance remaining intact.
Analysis · GNSS · Manufacturing
Genasys disclosed preliminary Q3 FY2026 revenue of $7.0–$7.5 million, well below the $15.5 million reported in Q2, alongside an adjusted EBITDA loss of up to $3.3 million. The shortfall stems from temporary supply chain issues on the CROWS II program and a deliberate pause on the Puerto Rico EWS project pending customer payments—both now resolved. Management expects a record Q4 as delayed revenue converts, and the $69 million backlog supports the full-year outlook. Against a backdrop of recent high-cost debt extensions and liquidity pressure, the pre-announcement aims to reassure investors that the miss is timing-related, not a demand problem. The stock trades at $1.74, giving the company a market cap of about $80 million, so the revenue miss and cash burn are material.
At the time of this filing, GNSS was trading at $1.74 on NASDAQ in the Manufacturing sector, with a market capitalization of approximately $80.2M. The 52-week trading range was $1.40 to $2.70. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.